Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 12

Results For "Synthesis"

144 News Found

Kiran Mazumdar-Shaw elected as the Fellow of Royal Society of Edinburgh
News | March 24, 2022

Kiran Mazumdar-Shaw elected as the Fellow of Royal Society of Edinburgh

Kiran will be joining RSE's current Fellowship of around 1,700 Fellows who are recognized as being some of the greatest thinkers, researchers and practitioners working in or with Scotland


Thermo Fisher Scientific to showcase global innovation at DCAT Week 2022
Medical Device | March 22, 2022

Thermo Fisher Scientific to showcase global innovation at DCAT Week 2022

Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers


Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine
Biotech | March 22, 2022

Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine

Data published in the prestigious journal ACS Central Science of the American Chemical Society


Lonza signs manufacturing agreement with Oasmia Pharmaceutical
News | March 21, 2022

Lonza signs manufacturing agreement with Oasmia Pharmaceutical

Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply


Sanofi moves forward with EUROAPI listing on Euronext Paris
Biotech | March 18, 2022

Sanofi moves forward with EUROAPI listing on Euronext Paris

EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions


Applications for PLI in bulk drugs extended till March 31st 2022
News | March 14, 2022

Applications for PLI in bulk drugs extended till March 31st 2022

A total of 49 projects have been approved so far for 33 critical APIs with a committed investment of Rs 3,685 crore


Sinocompound announces commercial-scale production of QPhos ligand
Biotech | March 03, 2022

Sinocompound announces commercial-scale production of QPhos ligand

The phosphine ligand is available on the kilo scale for the first time, providing scientists with a powerful solution for cross-coupling chemistry


Quotient Sciences integrates drug substance into Translational Pharmaceutics Platform
Biotech | February 18, 2022

Quotient Sciences integrates drug substance into Translational Pharmaceutics Platform

The newly enhanced drug development platform will help empower innovators with the fastest development timelines


ARVs bottom out while CRAMS growth continues for Laurus Labs: ICICI Direct
News | January 29, 2022

ARVs bottom out while CRAMS growth continues for Laurus Labs: ICICI Direct

The management guided for ARV API & formulation demand to be normalised from Q4FY22 and reiterated the aspiration of US $ 1 billion in sales by FY23: ICICI Direct


Advent to acquire controlling stake in Avra Labs
News | January 24, 2022

Advent to acquire controlling stake in Avra Labs

Avra Labs is a Hyderabad based contract manufacturing and research services (CRAMs) and specialty active pharmaceutical ingredients (API) manufacturer with four facilities across the states of Telangana and Andhra Pradesh